Reata Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
The report of Reata Pharmaceuticals Inc employs information from across the web and also from public filings by Reata Pharmaceuticals Inc. Jump to the end of the webpage for potential risks for Reata Pharmaceuticals Inc based on industry, location and marketcap. The article includes a questions and answers table on Reata Pharmaceuticals Inc.
Reata Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.8; made up of an environmental score of 2.3, social score of 6.0 and governance score of 6.0.
4.8
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 1082 | Respiratorius AB (publ) | 4.9 | High |
| 1082 | Shenzhen Chipscreen Biosciences Co Ltd | 4.9 | High |
| 1121 | Reata Pharmaceuticals Inc | 4.8 | High |
| 1121 | Heat Biologics Inc | 4.8 | High |
| 1121 | Curis Inc | 4.8 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Reata Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Reata Pharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Reata Pharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes Reata Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Reata Pharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Reata Pharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Reata Pharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes Reata Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Reata Pharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Reata Pharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes Reata Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Reata Pharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Reata Pharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Reata Pharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Reata Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Reata Pharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes Reata Pharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Reata Pharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes Reata Pharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Reata Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Reata Pharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Reata Pharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes Reata Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Reata Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Reata Pharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Reata Pharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Reata Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Reata Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Reata Pharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Reata Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Reata Pharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes Reata Pharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes Reata Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Reata Pharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes Reata Pharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Reata Pharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Reata Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney disease (CKD) caused by Alport syndrome, as well as for a form of pulmonary arterial hypertension associated with connective tissue disease; omaveloxolone that is Phase II clinical trial to treat Friedreich's ataxia; and conduct Phase 2 study for various form of CKD, such as IgA nephropathy, type 1 and type 2 diabetic CKD, hypertensive CKD, focal segmental glomerulosclerosis, and others. It is also developing RTA 901 for neurological diseases; and RTA 1701 for the potential treatment of a range of autoimmune, inflammatory, and fibrotic diseases. In addition, the company offers bardoxolone for the treatment of autosomal dominant polycystic kidney disease. Further, it has a strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize bardoxolone for renal, cardiovascular, diabetes, and various other related metabolic indications in Japan, China, Hong Kong, Macao, South Korea, Taiwan, Thailand, Singapore, the Philippines, Malaysia, Indonesia, Brunei, Vietnam, Laos, Myanmar, and Cambodia; and AbbVie Inc. to jointly research, develop, and commercialize all second- and later-generation Nrf2 activators for all indications other than renal, cardiovascular, and metabolic indications. The company was formerly known as Reata Discovery, Inc. and changed its name to Reata Pharmaceuticals, Inc. in May 2005. Reata Pharmaceuticals, Inc. was incorporated in 2002 and is headquartered in Plano, Texas.